FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION (Mark One) Washington D.C. 20549 For the transition period from _____________ to _____________ Commission file number: 000-28827 ________________________ PETMED EXPRESS, INC. (Exact name of registrant as specified in its charter) ________________________ (State or other jurisdiction of incorporation or organization) FLORIDA 65-0680967 (I.R.S. Employer Identification No.) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE A ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission file number: 000-28827 ______________________ PETMED EXPRESS, INC. (Exact name of registrant as specified in its chart ...

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number 000-28827 PETMED EXPRESS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Exact name of registrant as specified in its charter) (State or other jurisdiction of (IRS Employ ...

Petmed Express, Inc. (NASDAQ:PETS) Q4 2021 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Bruce Rosenbloom - CFO & Treasurer Matthew Hulett - CEO, President & Director Conference Call Participants Erin Wright - Morgan Stanley Corey Grady - Jefferies David Maley - 1102 Partners Operator Welcome to PetMed's Conference Call to Review the Financial Results for the Fourth Quarter and Fiscal Yearend March 31, 2022. [Operator Instructions]. At the request of the company, this conference call ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission file number: 000-28827 PETMED EXPRESS, INC. (Exact name of registrant as specified in its charter) Florida 65-0680 ...

PetMed Express, Inc. (NASDAQ:PETS) Q3 2021 Results Earnings Conference Call January 24, 2022 4:30 PM ET Company Participants Matt Hulett - Chief Executive Officer Bruce Rosenbloom - Chief Financial Officer Conference Call Participants Erin Wright - Morgan Stanley Anthony Lebiedzinski - Sidoti & Company Corey Grady - Jefferies Ben Rose - Battle Road Research Operator Welcome to the PetMeds Conference Call to Review the Financial Results for the Third Fiscal Quarter ended on December 31, 2021. At the request ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission file number: 000-28827 ______________________ PETMED EXPRESS, INC. (Exact name of registrant as specified in its ...

PetMed Express, Inc. (NASDAQ:PETS) Q2 2021 Earnings Conference Call October 25, 2021 4:30 PM ET Company Representatives Matt Hulett - Chief Executive Officer Bruce Rosenbloom - Chief Financial Officer Conference Call Participants Anthony Lebiedzinski - Sidoti Steph Wissink - Jefferies Ben Rose - Battle Road Research Operator Welcome to the PetMeds Conference Call to Review the Financial Results for the Second Fiscal Quarter ended on September 30, 2021. At the request of the company, this conference call is ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION (Mark One) Washington D.C. 20549 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________ to _____________ Commission file number: 000-28827 ______________________ FORM 10-Q Securities registered pursuant to Section 12(b) of the Exchange Act: | T ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number 000-28827 PETMED EXPRESS, INC. (Exact name of registrant as specified in its charter) Washington, D.C. 20549 (State or other jurisdiction of (IRS Empl ...